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This study examined the eﬀect of surgeons’ volume on outcomes in lung surgery: lobectomies and wedge resections. Additionally,
the eﬀect of video-assisted thoracoscopic surgery (VATS) on cost, utilization, and adverse events was analyzed. The Premier
Hospital Database was the data source for this analysis. Eligible patients were those of any age undergoing lobectomy or wedge
resectionusingVATSforcancertreatment.Volumewasrepresentedbytheaggregateexperiencelevelofthesurgeoninasix-month
window before each surgery. A positive volume-outcome relationship was found with some notable features. The relationship is
stronger for cost and utilization outcomes than for adverse events; for thoracic surgeons as opposed to other surgeons; for VATS
lobectomiesratherthanVATSwedgeresections.Whiletherewasareductionincostandresourceutilizationwithgreaterexperience
in VATS, these outcomes were not associated with greater experience in open procedures.
1.Introduction
Lobectomies and wedge resections of the lung are performed
using either open thoracotomy or minimally invasive tech-
niques, particularly, video-assisted thoracoscopic surgery
(VATS). The literature documents many purported beneﬁts
of VATS for major lung surgeries, such as smaller incisions,
less pain, less blood loss, less respiratory compromise, faster
recovery times translating into shortened hospital lengths
of stay, and superior survival rates [1]. However, compared
to open procedures, VATS has higher equipment costs,
increased operating room times, and a learning curve for
both surgeons and operating room personnel [2].
During the past three decades, a large body of empirical
literature has established a positive relationship between
provider volume and patient health outcomes across various
medical and surgical procedures [3–10], with little attention
paid to thoracic surgery. This is important, as the magnitude2 Minimally Invasive Surgery
of the volume outcome eﬀect was found to vary across
health conditions and surgery procedures [8]. The reason
that greater volume is associated with better throughput,
clinical outcomes, and control over resources, is not well
understood. This relationship may be the result of surgeons’
“learning-by-doing” and/or the result of “selective referrals”,
where physicians with better outcomes command a higher
demand for their services [3].
To date, most of the work on volume outcome relations
was conducted at the hospital level, as opposed to the
surgeon level. In the case of lung surgery, patients who
received open lobectomy and other resections at high-
volume hospitals were less likely to experience postoperative
complications and enjoyed better long-term and short-
term survival rates [11–13]. A similar relationship between
hospital volume and patient outcomes has been observed
across patients receiving minimally invasive procedures; for
example, minimally invasive endovascular interventions for
patients with abdominal aortic aneurysms [14–16].
Recently, there is some evidence that the associations
between hospital volume and operative mortality are medi-
ated by surgeon volume [14, 17]. The volume of the surgeon
was found to have a greater inﬂuence on patient outcomes
than hospital volume [18]. This should come as no surprise,
as hospital volume is the aggregate of all participating
surgeons’ volumes. Surgeons make preoperative and intra-
operative decisions, aﬀect case selection, and determine the
appropriate surgical technique to be used. Studies of the
relationship between surgeon volume and outcomes for
cancer patients are mixed. A majority of cancer studies ﬁnd
that high-volume surgeons have a lower rate of operative
mortality, with the strength of the relationship varying by
condition and procedure [14, 19]. Conclusions may be
obscured by heterogenous deﬁnitions of high-volume across
studies and procedures [18].
Few studies have examined the relationship between
surgeon volume and operative mortality for lobectomies and
wedge resections [18,20,21].Inonesuchstudy,highvolume
surgeons were found to have less locoregional recurrence
of cancer, but no diﬀerences were observed for mortality
[20]. While thoracic surgeons were more likely to perform
lobectomies and wedge resections using VATS, adjusting for
surgeon and hospital volume, lung cancer patients treated by
general thoracic surgeons had a lower probability of death
than those treated by cardiothoracic surgeons or general
surgeons [21]. A number of case studies based on either a
single center or a single surgeon found greater experience
with VATS to improve such patient outcomes as blood loss,
recurrence, operation time, surgeon-related thoracotomy
conversions, and readmissions [22–24].
Understanding volume-outcome relationships is of con-
siderable practical importance because it quantiﬁes the
eﬀects of experience on clinical outcomes. However, experi-
encemustberelevanttoperformance.Eventhoughsurgeons
often use diﬀerent techniques (e.g., open procedure versus
VATS), studies have not accounted for technique-speciﬁc
experience in calculating volume. To our knowledge, this is
theﬁrststudytoaccumulateexperiencewithVATSseparately
from experience with open procedure, as the two techniques
command diﬀerent surgical skills. Information regarding
skill development through practice is an important factor
that may aﬀect patient decisions of where to seek treatment
and provider decisions about where to refer their patients.
Furthermore, transitioning from open to VATS procedures
is not trivial, hence it is important to study the degree of
transferability of experience across the two procedures [25].
Volume-outcome studies of cancer patients have
reported mortality, inpatient length-of-stay, readmissions,
and several speciﬁc clinical indicators, such as blood loss
and perioperative complications [26, 27]. However, greater
experience can manifest itself in additional ways. Recent
studies documented variations among physicians in their
ability to shorten the length-of-stay for their patients,
reduce resource utilization, improve quality, and reduce the
likelihood of hospital-borne infections.
This current work aims to quantify the impact of a
surgeon’s volume on outcomes in lung surgery, adjusted
for other potential explanatory variables. We studied per-
formance on lobectomies and wedge resections separately
and accounted for the experience of surgeons as represented
by six-month case volumes using both VATS and open
techniques. Also, we analyzed the eﬀect of this technique-
speciﬁc experience on inpatient costs, length of surgery,
lengthofstay,aswellasthelikelihoodandnumberofadverse
surgical events.
2.MaterialsandMethods
A protocol describing the analysis objectives, criteria for
patient selection, data elements of interest, and statistical
methods was submitted to the New England Institutional
Review Board (NEIRB), and exemption was obtained.The
study was funded by Ethicon Endo-Surgery Inc. (Cincinnati,
Ohio, USA).
2.1. Data Source. This study utilizes the Premier Hospital
Database,whichcontainsclinicalandutilizationinformation
on patients receiving care in over 600 USA hospitals and
ambulatory surgery centers across the nation. The database
contains complete patient billing, hospital cost, and coding
histories from more than 25 million inpatient discharges
and 175 million hospital outpatient visits. Since VATS is
a new technology, the analyzable dataset was restricted to
procedures occurring in 2007-2008. Only data that were
anonymized with regard to patient identiﬁers were used.
2.2. Patients and Procedures. Eligible patients were those of
any age undergoing VATS lobectomy or wedge resection for
cancer. International Classiﬁcation of Diseases, 9th Revision
(ICD-9) diagnosis codes and procedure codes for identifying
lobectomy and wedge resection procedures, cancer diag-
noses, comorbid conditions, and all adverse events are listed
in Tables 7–10.
2.3. Volume Outcome Variable. T h ev o l u m em e a s u r et y p i -
cally used in previous research utilized subsequent volume
to predict outcomes. For example, many studies deﬁnedMinimally Invasive Surgery 3
Table 1: Patient characteristics.
Procedure∗ VATS lobectomy VATS wedge resection
All surgeons
(including thoracic)
Thoracic surgeons
(only)
All surgeons
(including thoracic)
Thoracic surgeons
(only)
Total N 716 546 1,982 1,350
(% of total N = 2,698) (26.54%) (20.24%) (73.46%) (50.04%)
Age average (SD) 66.68 (11.27) 66.51 (10.96) 61.09 (15.39) 61.37 (14.57)
<40 0.01 0.01 0.10 0.09
41–50 0.07 0.08 0.12 0.12
51–60 0.20 0.20 0.20 0.21
61–70 0.32 0.33 0.29 0.29
71–80 0.30 0.28 0.24 0.24
>80 0.10 0.10 0.06 0.06
Race
Caucasian 0.79 0.84 0.74 0.79
African American 0.07 0.07 0.08 0.09
Other 0.13 0.10 0.18 0.13
Gender
Female 0.55 0.55 0.53 0.53
Male 0.45 0.45 0.47 0.47
Marital status
Married 0.59 0.62 0.54 0.58
Unmarried 0.41 0.38 0.46 0.42
Insurance type
Commercial 0.07 0.07 0.07 0.07
Medicare 0.60 0.60 0.49 0.49
Medicaid 0.03 0.02 0.05 0.05
Managed care 0.28 0.30 0.35 0.35
Other 0.03 0.02 0.04 0.03
Malignancy indication∗∗
Primary neoplasm of the lung 0.96 0.95 0.86 0.85
Metastases from other primary malignancy 0.04 0.05 0.14 0.15
Illness severity level
APR-DRG Severity Level (1, 2) 0.78 0.79 0.87 0.86
APR-DRG Severity Level (3, 4) 0.22 0.21 0.13 0.14
∗All procedures are inpatient. CPT and ICD codes for resections in Table 7.
∗∗ICD codes for lung cancer in Table 8.
physician volume as the number of surgeries done over
a speciﬁc time period and used that measure to predict
outcomes of each surgery performed within that same time
period [8, 9, 12, 14, 28]. As a result, experience not yet
acquired was used to describe current performance, which
could potentially overestimate the inﬂuence of volume on
surgeon outcomes.
For each outcome-surgeon combination, our measure
of volume represented the aggregate experience level of the
surgeon. Volume-accumulated experience over running six-
month windows involved recording surgeons’ volume at a
given date as the number of procedures accumulated during
the prior six months. This measure is more precise than ﬁxed
calendarperiods and wasused extensively in theliterature, as
it responds instantaneously to any changes in the surgeon’s
recent experience proﬁle. Experience accumulation with
moving, rather than ﬁxed, windows can be viewed as
smoothing the calendar step function and alleviating the
imprecision that increases for observations occurring toward
the end of the observation period [29].
2.4. Statistical Analyses. Initial counts, percentages, means,
andstandarddeviationsforpatientdemographics,comorbid
conditions, hospital characteristics, as well as safety utiliza-
tion and cost outcomes were summarized separately for
VATS lobectomy versus VATS wedge resection and separately
for thoracic surgeons versus all surgeons using descriptive
statistics. Type of surgeon (thoracic versus general) was
identiﬁed via physician identiﬁcation codes provided in the
database.4 Minimally Invasive Surgery
Table 2: Comorbid conditions∗, ∗∗.
VATS lobectomy VATS wedge resection
All surgeons
(including thoracic)
Thoracic surgeons
(only)
All surgeons
(including thoracic)
Thoracic surgeons
(only)
Total N (2,698) 716 546 1,982 1,350
Myocardial infarction, acute or old 0.11 0.12 0.08 0.09
Congestive heart failure 0.07 0.07 0.07 0.08
Other chronic or unspeciﬁed heart failure 0.02 0.02 0.02 0.03
Peripheral vascular disease 0.10 0.10 0.08 0.08
Dementia 0.03 0.03 0.02 0.01
Chronic pulmonary disease 0.50 0.50 0.47 0.49
Connective tissue disease 0.03 0.03 0.05 0.05
Liver disease 0.05 0.05 0.06 0.06
Chronic viral hepatitis 0.01 0.01 0.01 0.01
Renal insuﬃciency, chronic 0.04 0.04 0.05 0.05
Diabetes mellitus 0.19 0.18 0.19 0.20
∗Proportions of comorbid conditions existing for patients any time during or before procedure stay in Premier database (beginning in 2000).
∗∗ICD codes for these variables are found in Table 10.
Table 3: Hospital characteristics.
VATS lobectomy VATS wedge resection
All surgeons
(including thoracic)
Thoracic surgeons
(only)
All surgeons
(including thoracic)
Thoracic surgeons
(only)
Total N (2,698) 716 546 1,982 1,350
Census region
Northeast 0.22 0.22 0.21 0.17
Midwest 0.12 0.11 0.24 0.23
South 0.51 0.51 0.41 0.45
West 0.15 0.16 0.14 0.15
Location
Urban 0.96 0.96 0.95 0.96
Nonurban 0.04 0.04 0.05 0.04
Type
Teaching 0.63 0.62 0.57 0.57
Nonteaching 0.37 0.38 0.43 0.43
Bed count
<200 0.05 0.04 0.06 0.05
200–400 0.20 0.21 0.26 0.25
400–600 0.29 0.31 0.30 0.35
>600 0.46 0.44 0.38 0.35
The safety outcomes of interest were pertinent adverse
events occurring during or up to 30–60 days after surgery.
A dichotomous variable was used indicating the existence of
an adverse event as well as a continuous variable tallying the
number of adverse events. Utilization outcomes were surgery
duration (hours) and hospital length of stay (days). Cost
outcomesweretotalhospitalcostsperpatient,bothﬁxedand
variable. Since we only studied VATS procedures, we did not
include costs for initial acquisition of the VATS equipment.
In addition, descriptive statistics for the volume explana-
tory variables are presented. The key explanatory variable
was each surgeon’s volume for lobectomy and wedge resec-
tion using VATS or open thoracotomy techniques. This
measureofvolumecorrespondedtotheaggregateexperience
level of the surgeon over running six-month windows.
Experience with open thoracotomy procedures may or may
not contribute to performance with VATS, but it is certainly
expected that experience speciﬁc to VATS will be the most
relevant in explaining outcomes for patients treated with
VATS.
Multivariable logistic regression analyses were estimated
for the adverse event binary outcome: the presence orMinimally Invasive Surgery 5
Table 4: Volume and outcomes measures∗.
VATS lobectomy VATS wedge resection
All surgeons
(including thoracic)
Thoracic surgeons
(only)
All surgeons
(including thoracic)
Thoracic surgeons
(only)
Total N (2,698) 716 546 1,982 1,350
Inpatient costs (dollars) 19,697 19,271 13,058 13,127
[10,670] [10,934] [8,669] [9,157]
Length of surgery (hours) 4.079 4.008 2.537 2.557
[1.477] [1.439] [1.079] [1.098]
Length of stay (days) 5.753 5.676 3.944 3.952
[4.122] [4.314] [3.384] [3.426]
Likelihood of adverse event 0.571 0.557 0.435 0.436
[0.495] [0.497] [0.496] [0.496]
Number of adverse events 1.126 1.092 0.722 0.740
[1.361] [1.347] [1.062] [1.094]
VATS six-month volume 28.42 31.64 22.30 24.59
[30.80] [33.57] [27.11] [30.56]
Open lobectomy six-month volume 5.27 5.46 5.52 5.38
[4.54] [4.51] [5.48] [4.85]
Open wedge Res six-month volume 3.66 3.73 4.02 3.97
[3.11] [2.89] [3.75] [3.43]
∗Standard deviations are reported in brackets.
∗∗ ICD codes for these variables are found in Table 10.
Table 5: Multivariable results for cost, utilization, and adverse events.
VATS lobectomy VATS wedge resection
All surgeons
(including thoracic)
Thoracic surgeons
(only)
All surgeons
(including thoracic)
Thoracic surgeons
(only)
Total N (2,698) 716 546 1,982 1,350
Inpatient costs (dollars)
Regression coeﬃcient −0.066∗∗∗ −0.098∗∗∗ −0.0436∗∗∗ −0.0468∗∗∗
[0.0158] [0.0170] [0.00904] [0.0104]
Length of surgery (hours)
Regression coeﬃcient −0.045∗∗∗ −0.074∗∗∗ −0.0475∗∗∗ −0.0317∗∗∗
[0.0135] [0.0149] [0.0077] [0.0084]
Length of stay (days)
Regression coeﬃcient −0.096∗∗∗ −0.117∗∗∗ −0.0778∗∗∗ −0.0665∗∗∗
[0.0207] [0.0237] [0.0129] [0.0141]
Likelihood of adverse events
Regression coeﬃcient −0.002∗ −0.002∗∗∗ −0.0005 −0.00098
[0.0009] [0.0010] [0.0006] [0.0007]
Number of adverse events
Regression coeﬃcient −0.083∗∗∗ −0.142∗∗∗ −0.0119 −0.0273
[0.0396] [0.0493] [0.0269] [0.0292]
Estimated marginal eﬀects are reported, standard deviations are reported in brackets ∗ and ∗∗∗ indicate signiﬁcance at the 10% and 1% levels.
absence of speciﬁc individual events. Ordinary least squares
(OLS)regressionwasusedforallothercontinuousoutcomes
such as hospital costs, surgery time, length of stay, and
number of adverse events. For all models, in addition to
the volume measures, the following explanatory variables
were included: age, gender, race, marital status, insurance
type,diagnosis(metastasisversusprimarycancer),comorbid
conditions (e.g., diabetes), All Patient Reﬁned-Diagnosis-
Related Groups (APR-DRGs) severity index (an index of
comorbidity unique to the Premier database that reﬂects6 Minimally Invasive Surgery
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Table 7
Pulmonary lobectomy CPT codes and ICD-9 codes sets
Open procedures
CPT 32480 Removal of lung, other than total pneumonectomy; single lobe (lobectomy)
ICD 32.49 Other lobectomy of lung
VATS procedures (i.e., via thoracoscopy)
CPT 32663 Thoracoscopy, surgical; with lobectomy, total or segmental
ICD 32.41 Thoracoscopic lobectomy of lung
Wedge resection CPT codes and ICD-9 codes sets
Open procedures
CPT 32484 Removal of lung, other than total pneumonectomy; single segment (segmentectomy)
CPT 32500 Wedge resection
ICD 32.39∗ Other and unspeciﬁed segmental resection of lung
ICD 32.29 Other local excision or destruction of lesion or tissue of lung (used for wedge resection)
VATS procedures (i.e., via thoracoscopy)
CPT 32657 Thoracoscopy, surgical; with wedge resection of lung, single or multiple
ICD 32.30∗ Thoracoscopic segmental resection of lung
ICD 32.20 Thoracoscopic excision of lesion or tissue of lung (used for thoracoscopic wedge resection)
∗Codes 32.30 and 32.39 became eﬀective on October 1, 2007. Prior to that date, the codes were simply 32.3 which did not diﬀerentiate between open and
thoracoscopic excisions. Due to this lack of information in the ICD codes, data for this project was limited to discharges on or after October 1, 2007.
Table 8: ICD-9 codes for index diagnosis.
Indications for surgery
Malignant
Primary neoplasm of the lung 162.x, 209.21∗
Metastatic site 197.0
∗ICD code 209.21 (malignant carcinoid tumor of the lung) came into
existence on October 1, 2008. Prior to October 1, 2008, this type of lung
cancer was coded together with 162.x.
preoperative severity level), census region of hospital, rural
versus urban hospitals, teaching versus nonteaching hospi-
tals, and number of hospital beds.
Using these explanatory variables, multivariable models
were estimated to isolate the eﬀe c t so fas u r g e o n ’ sV A T S
volume on adverse events, hospital costs, surgery time, and
length of stay. Because the cost and utilization variables
were right skewed, they were converted to natural logarithms
to normalize their distributions, although the results were
not sensitive to this transformation. Missing data or values
of zero were not included in the OLS regression models.
WeightsprovidedinthePremierdatabasewereusedtotrans-
form the results in a manner that permitted generalizability
to the USA population. All analyses were performed using
Stata Version 10 (StataCorp LP, College Station, Texas, USA).
3. Results
Of 7,137 patients in the database with elective, inpatient
resectionsforlungcancer,atotalof2,698patientsunderwent
lobectomy (n = 716) or wedge resection (n = 1982) using
VATS. More than 70% of these procedures were performed
bythoracicsurgeons(n = 1,896).Apatientattritiondiagram
is shown in Figure 1. Characteristics of eligible patients are
summarized in Table 1. There were slightly more females
than males in all four samples, and most patients in all
samples were over 60 years of age and covered by Medicare.
Most patients were Caucasian, with primary (as opposed
to metastatic) neoplasm of the lung and only minimal to
moderate illness severity level, as measured by the APR-
DRG severity index. As expected, the severity index for
patients undergoing lobectomy was higher than for patients
undergoing wedge resection. Patient characteristics within
procedure (lobectomy versus wedge resection) were similar
across the thoracic surgeons sample and the all surgeons
sample.
The distribution of speciﬁc patient comorbidities is
shown in Table 2. The most frequent comorbidities reported
were chronic obstructive pulmonary disease (COPD), dia-
betes mellitus, and heart disease. The distribution of these
conditions is similar across all samples.
A total of 237 hospitals contributed data on VATS
lobectomies and wedge resections. Patient-weighted hospital
characteristics for the four samples are reported in Table 3.
Compared with patients undergoing VATS wedge resection,
patients undergoing VATS lobectomy were more likely to
receive the procedure in a teaching hospital (63% versus
57%)andinahospitalwithover600beds(46%versus38%).
All samples exhibit similar demographic distributions.
Average hospital costs, surgery time, length of hospital
stay, the likelihood, and number of adverse events, as
well as the surgeons’ volume measures for each sample
were examined prior to multivariable modeling. The data
suggest that, on average, VATS lobectomies cost hospitals
more than VATS wedge resections ($19,697 versus $13,058)
are associated with both longer surgery time (four hours
versus 2.5 hours) and longer lengths of hospital stay (5.7
days versus 3.9 days). Furthermore, patients undergoing
lobectomyhadahigherlikelihoodofexperiencinganadverse8 Minimally Invasive Surgery
Table 9: Postoperative procedure-speciﬁc complications.
Postoperative procedure-speciﬁc complications∗ Postoperative code
Pulmonary
Acute respiratory failure 518.81, 518.84, 518.5 997.39
Spontaneous tension pneumothorax 512.0 997.39
Atelectasis/pulmonary collapse 518.0 997.39
Empyema 510.9 998.59
Bronchopleural ﬁstula 510.0 998.59
Air leak and other pneumothorax 512.1, 512.8
Chylothorax 457.8
Pneumonia 480.x to 486, 507.0 997.39
Other pulmonary infections and inﬂammation 487.0, 490, 491.21–491.22, 511.0–511.1, 511.89, 511.9,
513.x, 519.01 997.39
Cardiac
Arrhythmia 427.xx 997.1
Acute myocardial infarction 410.xx 997.1
Acute heart failure/pulmonary edema 428.1, 428.21, 428.23, 428.31, 428.33, 428.41, 428.43,
514, 518.4 997.1
Vascular/thromboembolic
Acute pulmonary embolism/infarction 415.1x
Acute deep venous thrombosis of extremities 453.4x, 453.8, 453.9
Neurological
Acute cerebrovascular accident (stroke) 433.x1, 434.x1, (997.02) 997.02
Transient cerebral ischemia/attack (TIA) 435.x, 437.1 997.09
Intracranial hemorrhage (includes hemorrhagic
stroke) 430–432.x 997.02
Wound complications
Dehiscence 998.30, 998.31, 998.32, 998.3
Hematoma/seroma complicating a procedure 998.12–998.13, 998.51
Cellulitis 998.59 plus 682.2
Other postoperative infection, including other
(noncellulitis) wound infection
998.59 when 510.9, 510.0, 038.xx, 790.7, 995.9x, 682.2
are NOT also present
Other
Perforations organ or vessels 998.2
In-hospital deaths Obtained from Premier variable
Sepsis 038.xx, 790.7, 995.9x 998.59
Other postoperative complications 997.xx EXCEPT 997.02, 998.0, 998.11, 998.33, 998.4,
998.6, 998.7, 998.8x, and 998.9
Conversion from /VATS to OPEN V64.42
∗All procedures are inpatient.
event compared to patients undergoing wedge resection
(0.57 versus 0.43) and had a higher number of adverse events
on average (1.13 events versus 0.72 events).
This study tracks 575 surgeons performing lobectomies
or wedge resections using VATS (366 of whom were thoracic
surgeons). Patients treated by thoracic surgeons using VATS
lobectomy had lower inpatient costs and shorter length
of stay compared with patients seen by general and other
surgeons. While these eﬀects were statistically signiﬁcant at
the 1% level, they were evidently small. No other statistically
meaningful diﬀerences between thoracic and other surgeons
were found for patients treated using VATS wedge resection
or for other outcomes (i.e., length of surgery, likelihood of
adverse event, and number of adverse events).
Surgeons’ six months experience with VATS varies by
sample (Table 4). The most experienced surgeons, on aver-
age, are found in the sample of thoracic surgeons performing
VATSlobectomies,31.6procedures.Thisaveragedecreasesto
2 2 . 3p r o c e d u r e sw h e nc o n s i d e r i n ga l ls u r g e o n sp e r f o r m i n g
VATS wedge resections. Six months experience, for theseMinimally Invasive Surgery 9
Lobectomy or wedge resection procedures 
performed using VATS
admitted thought the emergency room
have 6 months of previous data
Total number of hospital visits in Premier 
database between October 2007 
and December 2008
lobectomy or wedge resection
Procedures between October 2007 and 
of data for previous experience 
calculations
Procedures that are not elective 
admissions
Procedures where the patients were 
admitted through the emergency room
Lobectomy or wedge resection 
procedures performed using open 
thoracotomy
N = 45,990,618
Lobectomy or wedge resection 
procedure visits
N = 14,854
Hospital visits that did not have a 
N = 45,975,764
March 2008 that do not have 6 months
N = 5,720
N = 1,997
N = 102
N = 4,337
N = 2,698
Lobectomy or wedge resection procedures in 
April–December 2008, elective and not  
N = 7,035
N = 7,137
N = 9,134
Elective procedures in April–December 2008
between April and December 2008, which do 
Lobectomy or wedge resection procedures
Figure 1: Attrition diagram. Thoracotomy: open versus VATS.
surgeons, with open lobectomies and open wedge resection
was lower, 5.4 procedures and 3.9 procedures, respectively,
for the entire sample.
3.1. Multivariable Findings. Given the possibility of con-
founders in these group comparisons of outcomes, we
performed multivariable regression analyses, adjusting for a
number of potential confounders, including patient demo-
graphics, metastatic versus primary cancer, comorbid condi-
tions, APR-DRG severity index, and hospital characteristics.
The results of these adjusted analyses of costs, surgery
time, length of stay, likelihood of adverse event, and the
number of adverse events are shown in Table 5. For ease of
interpretation, we report the estimated marginal eﬀects for
each one of the 40 models presented in Table 5.T h er e p o rt e d
marginal eﬀects measure the expected instantaneous change
in each one of our ﬁve-outcome variables as a function of a
changeinsurgeons’VATSvolume,whilekeepingalltheother
covariates constant. Note that, for each outcome of interest,
we compared the estimated marginal eﬀects obtained from
an unadjusted analysis with the estimated marginal eﬀects
from the multivariable analysis described above. (Note: only
adjusted ﬁndings are reported in Table 5).
In the unadjusted analysis for the all surgeons lobectomy
sample, doubling the average surgeon’s volume was associ-
ated with a 10% reduction in inpatient cost ($2,029), a 5%
r eductioninsurgerytime(13min ut es),anda15%r eduction
in length-of-stay (approximately one day). The eﬀect of
experience on the likelihood of an adverse event, while
statistically signiﬁcant, was small in magnitude. Increased
surgeons’ experience was associated with a reduction of
one adverse event in one of every ﬁve patients. Even after
adjusting for the variables detailed in Tables 1 through 3,a l l
the ﬁndings above persist.
The ﬁrst and second columns of Table 5 reports the
analysis for lobectomies for all surgeons and then surgeries
performed exclusively by thoracic surgeons. For the most
part, the volume-outcome relationship for thoracic surgeons
isstronger.Doublingofthethoracicsurgeonsexperiencewas
associated with a 13% reduction in inpatient cost ($2,409)10 Minimally Invasive Surgery
Table 10: Comorbid Conditions.
Comorbid conditions (existing for patient any time during or
before procedure stay in Premier data)
Myocardial infarction, acute or old 410.xx, 412
Congestive heart failure 428.0
Other chronic or unspeciﬁed heart
failure
428.20, 428.22, 428.30,
428.32, 428.40, 428.42,
428.9
Peripheral vascular disease 440.xx, 443.8x, 443.9
Dementia
290.xx, 294.xx, 331.0,
331.11, 331.19, 331.2,
331.7, 331.82
Chronic pulmonary disease 490.xx–494.xx, 495.x, 496,
500–505
Connective tissue disease 710.xx, 714.xx
Liver disease 571.x, 572.x, 573.xx
Chronic viral hepatitis
070.22–070.23,
070.32–070.33, 070.44,
070.54
Renal insuﬃciency, chronic 585.xx
Diabetes mellitus 249.xx, 250.xx
a n da7 %r e d u c t i o ni ns u r g e r yt i m e( 1 8m i n u t e s ) .A l lo t h e r
results were similar to the ones obtained for all surgeons.
The second and third columns of Table 5 repeat the
analysisforpatientsundergoingVATSwedgeresection.Here,
for most outcomes and speciﬁcations, the volume-outcome
relationship appears much weaker. Doubling of the surgeon’s
experience was associated with a 3% reduction in inpatient
cost ($389), a 2% reduction in surgery time (3 minutes),
and an 8% reduction in hospital length of stay (a third of
a day). The results were similar when considering the most
saturated model and when limiting the sample to procedures
performed solely by thoracic surgeons. The only exception
was the reduction in cost for the thoracic surgeon sample,
which was 5% ($659).
Table 6 reports results from models similar to those
reported in Table 5, and includes two additional variables:
the surgeon’s six-months experience with open lobectomies
and the surgeon’s six-months experience with open wedge
resections. The two additional volume measures allow for
assessing the contribution of competing sources of learning.
For example, for the VATS lobectomy sample, one may argue
that any experience with lobectomy (open or VATS) may
be an important contributor for performance. This is tested
directly in Table 6. Overall we ﬁnd the volume-outcome
relationship for experience with VATS to be similar in sign,
magnitude, and statistical signiﬁcance to those described in
Table 5. Experience with open lobectomy did not have an
eﬀectonoutcomesforpatientstreatedwithVATSlobectomy,
with the exception of the number of adverse events, where
greater experience with open lobectomy was associated with
a small reduction in the number of adverse events for
VATS lobectomy. Similarly, experience with open wedge
resection was associated with a reduction in inpatient cost
and length of stay beyond the reductions associated with
greater experience with VATS.
4. Discussion
An important strength of the Premier database is that it
provides very large numbers of patients, surgeons, and
procedures on a nationwide scale. Obtaining this extremely
largesamplesizefromapracticalsettingallowsresearchersto
better understand processes such as the relationship between
surgeons’ volume and outcomes. In turn, this analysis
provides hospitals, patients, and surgeons with a quantiﬁable
measure of the beneﬁts of surgeons’ volume on outcomes in
lung surgery. The sample size and large number of elements
in the Premier database allows for analyzing the eﬀect of
experience with VATS on inpatient costs, length of surgery,
lengthofstay,aswellasthelikelihoodandnumberofadverse
surgical events.
Inthisretrospectiveanalysis,weﬁndevidenceofvolume-
outcome relationship. The relationship is stronger (1) for
cost and utilization outcomes as opposed to adverse events,
(2) for thoracic surgeons rather than other surgeons, and
(3) for VATS lobectomy procedures more than for VATS
wedge resection procedures. Finally, we ﬁnd that while there
was a reduction in cost and resource utilization associated
with greater experience with VATS, these outcomes were
not strongly linked with greater experience with open
procedures. Thus, by and large, performance with VATS is
associated primarily with experience with VATS.
The choice between VATS and open lobectomy has
implications for the surgeon’s learning proﬁle, as the
reduction in cost and resource utilization associated with
greater experience with VATS were much larger than those
associated with greater experience with open procedures.
This ﬁnding reinforces the need for surgeons’ specialization
and centralization of delivery for VATS.
There were certain limitations of this study. This is a ret-
rospective analysis from a transactional database (Premier)
and not a prospective analysis where randomization and
more detailed information about patients and procedures
could be collected. For instance, it would have been of
interest to examine the inﬂuence of additional patient
characteristics, such as weight or BMI, and more procedure-
related details. Nevertheless, we include numerous controls
in our analysis, particularly, controls for patient characteris-
tics [30] and hospital characteristics [12].
Another limitation, and a topic that can be the focus
of future research, is the lack of information on surgeons’
characteristics. In particular, data associated with surgeons’
characteristics (e.g., years in practice, graduate of which
medical school, completion of fellowship, etc.) would be of
interest. This information may be important as surgeons do
not randomly adopt VATS, and the results may therefore be
biased if the most able surgeons are also the ones who adopt
and utilize VATS extensively.
5. Conclusions
Our analysis of a large, nationally representative hospital
database revealed three key ﬁndings: (1) there is a reduction
in cost and resource utilization associated with greater expe-
rience with VATS, especially for VATS lobectomy for lungMinimally Invasive Surgery 11
cancer; (2) thoracic surgeons have better VATS outcomes
than non-thoracic surgeons; (3) greater experience with
open procedures does not correlate with better VATS out-
comes. These ﬁndings have implications for the organization
of health care delivery of both minimally invasive and open
procedures.
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